It has been shown that the assessment of single biomarker is not accurate enough to be used as diagnostics tool due to their not-specific nature, while the measurement of selected inflammatory proteins especially with CXCR4 in combination with classical tumor markers may improve the diagnosis of EC patients. Here, CXCR4 is linked to neoplasm.